We were suddenly hit by the COVID-19 pandemic. I decided to shift the focus of the podcast to cover the pandemic as it was consuming all of us and started to have an impact on patients and physicians, but also on everyone in the general public. I invited Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, to break down current exposure risk and mortality rates of COVID-19, preventative steps to avoid exposure, and promising therapies on the horizon.
Emily stated that this was a pandemic on this episode almost 2 weeks before The WHO admitted that we are dealing with one. I was fortunate to win an award for this episode. It was a communication award of distinction. I am humbled to win any kind of award, but grateful to Dr. Landon for this one.
This episode was recognized as a Winner of Distinction in the 26th Annual Communicator Award.
Dr Nabhan and Dr Landon have no relevant financial disclosures. Click here to learn more about Emily Landon. This podcast is produced by the Journal of Clinical Pathways.
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
